Hospital Universitario de Puerto Real-ko ikertzaileekin lankidetzan egindako argitalpenak (79)

2024

  1. DOLAMA 200: Effectiveness and Safety of a Dual Therapy with Dolutegravir Plus Lamivudine in Treatment-Experienced HIV-1 Infected Real World Participants in Spain

    Viruses, Vol. 16, Núm. 2

2023

  1. Identifying patients with prostate cancer at increased risk for haematuria during anticoagulation for venous thromboembolism

    Thrombosis Research, Vol. 232, pp. 54-61

  2. Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice

    Journal of Antimicrobial Chemotherapy, Vol. 78, Núm. 10, pp. 2591-2596

  3. Scientific assessment and balance of the 14th Congress and 21st Conference of the Spanish Society of Prison Health held at Jerez de la Frontera, Cadiz

    Revista Espanola de Sanidad Penitenciaria

  4. Sex-Related Differences in Patient Characteristics, Risk Factors, and Symptomatology in Older Adults with Pulmonary Embolism: Findings from the SERIOUS-PE Study

    Seminars in Thrombosis and Hemostasis, Vol. 49, Núm. 7, pp. 725-735

2022

  1. Antioxidant Activity and Polyphenols Content of Artemisia Herba-Alba Extract and their Cytotoxicity against Human Lung Cancer Cells NCI-N417

    Journal of Herbs, Spices and Medicinal Plants, Vol. 28, Núm. 4, pp. 337-350

  2. HEPATITIS C VIRUS SCREENING AND LINKAGE TO CARE IN MENTAL HEALTH UNITS: AN OPPORTUNITY FOR HCV ELIMINATION

    Actas espanolas de psiquiatria, Vol. 50, Núm. 2, pp. 120-121

  3. High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug use

    Journal of Infection, Vol. 85, Núm. 3, pp. 322-326

  4. Prognostic Impact of Active Cigarette Smoking on Mortality in Patients with Acute Venous Thromboembolic Events, Findings from Real World Data

    Medicina (Lithuania), Vol. 58, Núm. 2

  5. Venous thromboembolism in patients with autoimmune disorders: a comparison between bleeding complications during anticoagulation and recurrences after its discontinuation

    British journal of haematology, Vol. 197, Núm. 4, pp. 489-496

2021

  1. Acute hepatitis C virus infection and direct-acting antiviral drugs: Perfect combination to eliminate the epidemic?

    International Journal of STD and AIDS, Vol. 32, Núm. 13, pp. 1257-1260

  2. Case-control analysis of the impact of anemia on quality of life in patients with cancer: A Qca study analysis

    Cancers, Vol. 13, Núm. 11

  3. Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy

    Journal of Hepatology, Vol. 74, Núm. 4, pp. 801-810

  4. Impact of recent drug use on the efficacy of elbasvir/grazoprevir for HCV-infected people on opioid agonist therapy

    Journal of Viral Hepatitis, Vol. 28, Núm. 6, pp. 878-886

  5. Incidence of recently acquired hepatitis C virus infection among HIV-infected patients in southern Spain

    HIV Medicine, Vol. 22, Núm. 5, pp. 379-386

  6. Liver Stiffness-Based Strategies Predict Absence of Variceal Bleeding in Cirrhotic Hepatitis C Virus-Infected Patients With and Without Human Immunodeficiency Virus Coinfection After Sustained Virological Response

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 72, Núm. 5, pp. e96-e102

  7. Liver stiffness change with HCV cure in HIV-infected patients on non-nucleoside analogues

    Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 9, pp. 2375-2379

  8. Progression to hepatitis C virus micro-elimination in people living with HIV in Spain

    Clinical Microbiology and Infection

2020

  1. Effect of dapagliflozin on arterial stiffness in patients with type 2 diabetes mellitus

    Medicina Clinica, Vol. 154, Núm. 5, pp. 171-174

  2. Executive summary: Consensus document of GEHEP of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), along with SOCIDROGALCOHOL, SEPD and SOMAPA on hepatitis C virus infection management in drug users

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 3, pp. 127-131